Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 936,448 | 2,173,077 | 1,975,689 | 1,710,751 | 991,628 |
| Marketable Securities | 5,300 | 5,100 | 2,500 | 25,721 | 549,273 |
| Receivables | 37,913 | 35,228 | 38,440 | 36,597 | 34,843 |
| Other current assets | 748,944 | 740,134 | 614,592 | 781,839 | 766,372 |
| TOTAL | $1,728,605 | $2,953,539 | $2,631,221 | $2,554,908 | $2,342,116 |
| Non-Current Assets | |||||
| PPE Net | 13,230,470 | 13,267,730 | 13,661,820 | 13,493,110 | 14,287,400 |
| Investments And Advances | 876,233 | 870,801 | 753,054 | 735,823 | 1,012,477 |
| Other Non-Current Assets | 20,217 | 29,409 | 28,026 | 29,627 | 30,613 |
| TOTAL | $14,126,920 | $14,167,940 | $14,442,900 | $14,258,560 | $15,330,490 |
| Total Assets | $15,855,520 | $17,121,480 | $17,074,120 | $16,813,470 | $17,672,610 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 999,370 | 998,441 | 997,512 | 996,583 |
| Accounts payable and accrued liabilities | 115,338 | 118,690 | 105,239 | 102,709 | 121,843 |
| Accrued Expenses | 12,595 | 54,162 | 13,199 | 54,162 | 13,199 |
| Other current liabilities | N/A | N/A | N/A | 12,400 | N/A |
| TOTAL | $127,933 | $1,172,222 | $1,116,879 | $1,166,783 | $1,131,625 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,131,194 | 6,127,074 | 6,122,942 | 6,118,810 | 6,114,677 |
| Other Non-Current Liabilities | -38,663 | -115,211 | -156,034 | 156,446 | -67,863 |
| TOTAL | $6,142,494 | $6,135,574 | $6,135,242 | $6,121,310 | $6,124,577 |
| Total Liabilities | $6,270,427 | $7,307,796 | $7,252,121 | $7,288,093 | $7,256,202 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 597,432 | 601,823 | 607,138 | 607,224 | 607,222 |
| Common Shares | 108 | 109 | 108 | 107 | 107 |
| Retained earnings | 2,134,680 | 2,252,945 | 2,216,811 | 1,964,689 | 2,504,974 |
| Other shareholders' equity | 3,446,551 | 3,532,390 | 3,868,423 | 3,897,417 | 4,281,416 |
| TOTAL | $9,585,097 | $9,813,686 | $9,822,000 | $9,525,373 | $10,416,400 |
| Total Liabilities And Equity | $15,855,524 | $17,121,482 | $17,074,121 | $16,813,466 | $17,672,602 |